Position in DTIL
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$96,041
-$53,423 QoQ
Shares Held
12,219
-66.0% QoQ
Ownership
0.044%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#59
of 94 holders
Holding Since
Mar 2022
8 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in DTIL Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026XTX Topco Ltd holds $413,140,824 across 381 Biotechnology names. DTIL ranks #276 (0.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
30,522 | $19,031,687 | |
| 2 | ASND |
Ascendis Pharma A/S
|
43,289 | $11,546,042 | |
| 3 | BBIO |
BridgeBio Pharma, Inc.
|
116,611 | $8,685,187 | |
| 4 | MRNA |
Moderna, Inc.
|
123,281 | $8,633,368 | |
| 5 | JAZZ |
Jazz Pharmaceuticals plc
|
30,496 | $7,348,621 | |
| 6 | KYMR |
Kymera Therapeutics, Inc.
|
61,501 | $7,052,319 | |
| 7 | CYTK |
Cytokinetics Inc
|
80,743 | $6,878,496 | |
| 8 | PTCT |
Ptc Therapeutics, Inc.
|
81,923 | $6,682,459 |
All Filings in DTIL
Export CSV
8 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $96,041 | 12,219 | Shares | Defined | 2026-08-14 | |
| 2025-12-31 | $149,464 | 35,929 | Shares | Defined | 2026-02-17 | |
| 2024-12-31 | $67,459 | 17,706 | Shares | Defined | 2025-02-13 | |
| 2023-12-31 | $4,457 | 12,212 | Shares | Defined | 2024-02-13 | |
| 2022-12-31 | $99,466 | 83,585 | Shares | Defined | 2023-02-14 | |
| 2022-09-30 | $221,049 | 170,038 | Shares | Defined | 2022-11-14 | |
| 2022-06-30 | $130,905 | 81,816 | Shares | Defined | 2022-08-15 | |
| 2022-03-31 | $71,400 | 23,182 | Shares | Defined | 2022-05-13 | |
| No filing history on record for this holder in this stock. | ||||||